In Phase 2 obesity trials, the highest studied doses, particularly 12 mg weekly , produced the largest average body weight reductions
Li YF, Gauderman WJ, Conti DV, Lin PC, Avol E, Gilliland FD
Supports collagen production for improved skin elasticity
Systolic Blood Pressure Went Down 7.4 to 10.6 mmHg in People on Zepbound In the original study, participants who were overweight or obese (meaning they had a body mass index of 27 or greater) taking once-weekly tirzepatide injections of 5 milligrams (mg), 10 mg, or 15 mg for 72 weeks led to average weight reductions of 15 percent, 19.5 percent and 20.9 percent, respectively, compared with placebo
Compounding a drug that has no approved formulation in Australia sits in a grey area at best and an illegal one at worst